Madrigal Pharmaceuticals Financial Overview
Madrigal Pharmaceuticals's market cap is currently $13.11B. The company's EPS TTM is $-5.08; its P/E ratio is ―; Madrigal Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
